Beacon Cancer Care

Coeur d'Alene, Idaho 83814

0 studies enrolling now · 4 studies all time

What they study most

Locally Advanced or Metastatic Urothelial Carcinoma, Relapsed and/or Refractory Multiple Myeloma, Soft Tissue Sarcoma, Solid Tumor, Unresectable or Metastatic Melanoma

Studies at this site

• A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley) — Running, not enrolling
• PROCLAIM: CX-072-002: Study of PD-L1 Probody Therapeutic CX-072 in Combination With Other Anticancer Therapy in Adults With Solid Tumors — Stopped early
• Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma — APPROVED_FOR_MARKETING
• Expanded Access Program for Melphalan Flufenamide (Melflufen) in Triple Class Refractory Multiple Myeloma — APPROVED_FOR_MARKETING